Clinical Trial Update: Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens [Phase 3]

View source ↗

Summary

Phase 3 trial update for ceftazidime-avibactam in complicated urinary tract infection and complicated intra-abdominal infection has been completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Complicated Urinary Tract Infection

Drugs mentioned

• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Pfizer | Conditions: Complicated Urinary Tract Infection, Complicated Intra-abdominal Infection | Phase 3 | Status: COMPLETED | Results posted: 2015-12-14